Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 493.97 M528.36 M572.95 M593.94 M620.73 M 2.32 B Research & development ————— — Operating income 239.08 M370.28 M517.22 M484.93 M338.78 M 1.71 B Non-Operating Income, Total 4.08 M7.92 M17.03 M10.41 M-12.06 M 23.3 M Interest expense, net of interest capitalized 54.31 M59.58 M71.81 M75.75 M73.27 M 280.4 M Non-Operating Income, excl. Interest Expenses -50.47 M-55.8 M-68.08 M-71.39 M-73.27 M -268.54 M Unusual income/expense 239 K4.14 M13.31 M6.05 M-12.06 M 11.44 M Pretax income 188.85 M318.62 M462.44 M419.59 M256.36 M 1.46 B Equity in earnings 1.5 M2.6 M2.58 M—— — Taxes 39.88 M85.1 M119.61 M103 M24.93 M 332.63 M Non-controlling/minority interest 4.71 M4.27 M3.42 M1.14 M10.81 M 19.63 M After tax other income/expense ————— — Net income before discontinued operations 144.26 M229.25 M339.42 M315.45 M220.63 M 1.1 B Discontinued operations ————— — Net income 144.26 M229.25 M339.42 M315.45 M220.63 M 1.1 B Dilution adjustment ————— — Preferred dividends ————— — Diluted net income available to common stockholders 144.26 M229.25 M339.42 M315.45 M220.63 M 1.1 B Basic earnings per share (Basic EPS) 0.971.542.282.121.47 7.41 Diluted earnings per share (Diluted EPS) 0.961.522.242.081.45 7.29 Average basic shares outstanding 148.27 M148.45 M149.04 M148.79 M149.78 M — Diluted shares outstanding 150.96 M150.92 M151.5 M151.29 M152.09 M — EBITDA 430.74 M570.69 M726.96 M732.7 M600.5 M 2.63 B EBIT 223.06 M358.79 M489.89 M123.08 M334.82 M 1.31 B Cost of revenue 5.4 B5.77 B6.41 B6.62 B6.77 B 25.57 B Other cost of goods sold ————— — Depreciation & amortization (cash flow) 207.68 M211.9 M237.07 M609.62 M265.68 M 1.32 B